GSK: The Claes Oldenburg of Pharma
I should be in Philadelphia today attending CBI's iPharma conference, but I think I have the flu despite getting the flu vaccine, which I...
Google’s Rapidly Disappearing (Free) Organic Search Data: Impact on Pharma’s Ability to Measure the...
A conversation with Domenico Tassone, Vice-President of Digital Analytics & Operations at The Encima Group, about the privacy setting introduced by Google last year, which now lists referring keywords from organic search as
Baby Boomers Living Longer, But Less Healthy Lives!
I just read some surprising results of a study published in Arch Intern Med. (2013;173(2):1-2) regarding the overall health status of aging baby boomers...
A New Unmet Medical Need: Excess Adipose Tissue Syndrome
As reported by FierceBiotech (here), "Bayer Healthcare touted upbeat data from a pair of late-stage studies of an investigational drug targeting chin fat, setting...
“SMAC” – A New Buzzword for Pharma in 2013
No, I’m not talking about the Salsa Music Appreciation Club or the Students’ Museum Advisory Council of the Utah Museum of Fine Arts. I’m...
Novo Nordisk’s “Bait-and-Switch” Super Bowl Diabetes Marketing
Novo Nordisk's diabetes drug marketers are hitching on to the Super Bowl bandwagon. This morning, for example, I received an e-mail from Novo Nordisk's...
Pharma Marketing News Vol. 12, No. 1: 31 January 2013
Welcome to Volume 12, Issue #1 (31 Januray 2013) of Pharma Marketing News.
Pharma Marketing News Vol. 12, No. 1: 31 January 2013
Welcome to Volume 12, Issue #1 (31 Januray 2013) of Pharma Marketing News.
Pharma Needs to Step Up & Help Develop a Universal Flu Vaccine
Recently, I've been reading a lot about a "universal flu vaccine." A Bloomberg View piece, for example, points out that the greatest breakthrough in...
In a Pre-emptive Strike, Amgen & Genentech (Roche) Lobby States to Block Biosimilars
No doubt you've heard of how Amgen essentially paid off U.S. Senators to sneak a provision in the "fiscal cliff" bill that delays price...
